Despite being less frequently observed than gene amplification, several FGFR2 fusion genes have been identified in gastric cancer as well as in common bile duct cancer, hepatocellular carcinoma, pancreatic cancer, and sarcomas. The gene discussed is FGFR2; the disease is gastric cancer.